The influence of sulfated polysaccharides on the circulating levels of hyaluronan

Glycobiology

Volumn 7, Issue 8, 1997, Pages 1209-1214

  Gustafson, Stefan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Angiogenesis; Glycosaminoglycans; Hyaluronic acid; Metabolism; Turnover

Indexed keywords

CHONDROITIN SULFATE; DEXTRAN SULFATE; HYALURONIC ACID;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE METABOLISM; ENDOCYTOSIS; GEL PERMEATION CHROMATOGRAPHY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RETICULOENDOTHELIAL SYSTEM; URINARY EXCRETION;

ANIMALS; CELLS, CULTURED; CHONDROITIN SULFATES; CHROMATOGRAPHY, GEL; DEXTRAN SULFATE; HYALURONIC ACID; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; KINETICS; LIVER; MOLECULAR WEIGHT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031455991     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/7.8.1209     Document Type: Article

References (40)

1. Afify, A.M., Stern, M., Guntenhöner, M. and Stern, R. (1993) Purification and characterization of human serum hyaluronidase Arch. Biochem. Biophys., 305, 434-441.
2. Collier, M.A., Burba, D.A., DeBault, L.E., Painton, O.H. and Jones, E.W. (1991) In vivo kinetic study of intramuscular tritium-labeled polysulfated glycosaminoglycan in equine body fluid compartments and articular cartilage in an arthritis model. Acta Vet. Scand., 87, 266-267.
3. Conte, A., Volpi, N., Palmieri, L., Bahous, I. and Ronca, G. (1995) Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate. Arzneimittelforschung, 45, 918-925.
4. Engström-Laurent, A. and Hellström, S. (1990) The role of liver and kidneys in the removal of circulating hyaluronan. An experimental study in the rat. Connect Tissue Res., 24, 219-224.
5. Eriksson, S., Fraser, J.R.E., Laurent, T.C., Pertoft, H. and Smedsröd, B. (1983) Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver Exp. Cell Res., 144, 223-228.
6. Feinberg, R.N. and Beebe, D.C. (1983) Hyaluronate in vasculogenesis. Science, 220, 1177-1179.
7. Ferns, G.A.A., Konneh, M., Rutherford, C., Woolaghan, E. and Änggård, E.E. (1995) Hyaluronan (HYAL-BV 5200) inhibits neo-intimal macrophage influx after balloon-catheter induced injury in the cholesterol-fed rabbit. Atherosclerosis, 114, 157-164.
8. Folkman, J., Taylor, S. and Spillberg, C. (1983) The role of heparin in angiogenesis. Ciba Found. Symp., 100, 132-149.
9. Fraser, J.R.E, and Laurent, T.C. (1989) Turnover and metabolism of hyaluronan. In Evered, D. and Whelan, J. (eds.),The Biology of Hyaluronan. Ciba Foundation Symposium 143. Wiley, Chichester, pp. 41-52.
10. Fraser, J.R.E., Laurent, T.C., Pertoft, H. and Baxter, E. (1981) Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit Biochem. J., 200, 415-424.
11. Fraser, J.R.E., Alcorn, D., Laurent, T.C., Robinson, A.D. and Ryan, G.B. (1985) Uptake of circulating hyaluronic acid by the rat liver. Cellular localization in situ. Cell Tissure Res., 242, 505-510.
12. Fraser, J.R.E., Engström-Laurent, A., Nyberg, A. and Laurent, T.C. (1986) Removal of hyaluronic acid from the circulation in rheumatoid disease and primary biliary cirrhosis J. Lab. Clin. Med., 107, 79-85.
13. Fraser, J.R.E., Kimpton, W.G., Laurent, T.C., Cahill, R.N.P. and Vakakis, N. (1988) Uptake and degradation of of hyaluronan in lymphativ tissue. Biochem. J., 256, 153-158.
14. Gustafson, S. (1997) Hyaluronan in drug delivery. In Laurent, T.C. (ed.), The Chemistry, Biology and Medical Applications of Hyaluronan and its Derivatives. Portland Press, London, 14, 561-568.
15. Guslafson, S. and Björkman, T. (1997) Circulating hyaluronan, chondroitin sulphate and dextran sulphate bind to a liver receptor that does not recognize heparin. Glycoconjugate J., in press.
16. 125I-tyrosine: studies in vitro and in vivo in the rat. Glycoconjugate J., 11, 608-613.
17. Ialenti, A. and Di Rosa, M. (1994) Hyaluronic acid modulates acute and chronic inflammation. Agents Actions, 43, 44-47.
18. Knudson, C.B. and Knudson, W. (1993) Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J., 7, 1233-1241.
19. Langer, R., Brem, H., Falterman, K., Klein, M. and Folkman, J. (1976) Isolations of a cartilage factor that inhibits tumor neovascularization. Science, 193, 70-72.
20. Laurent, T.C. and Fraser, J.R.E. (1992) Hyaluronan. FASEB. J., 6, 2397-2404.
21. Laurent, T.C., Laurent, U.B.G. and Fraser, J.R.E. (1996) Serum hyaluronan as a disease marker. Ann. Med., 28, 241-253.
22. Laurent, U.B.G. and Laurent, T.C. (1981) On the origin of hyaluronate in blood. Biochem. Int., 2, 195-199.
23. Lebel, L., Smith, L., Risberg, B., Laurent, T.C. and Gerdin, B (1989) Increased lymphatic elimination of interstitial hyaluronan during E.coli sepsis in sheep. Am J. Physiol., 256 (Heart Circ. Physiol. 25), H1524-H1531.
24. Lee, A. and Langer, R. (1983) Shark cartilage contains inhibitors of tumor angiogenesis. Science, 221, 1185-1187.
25. Lees, V.C., Fan, T.P. and West, D.C. (1995) Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. Lab. Invest., 73, 259-266.
26. Lindahl, U., Cifonelli, J.A., Lindahl, B. and Roden, L. (1965) The role of serine in the linkage of heparin to protein J. Biol. Chem., 240, 2817-2820.
27. Lokeshwar, V.B., Lokeshwar, B.L., Pham, H.T. and Block, N.M. (1996) Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res., 56, 651-657.
28. McGary, C.T., Raja, R.H. and Weigel, P. H. (1989) Endocytosis of hyaluronic acid by rat liver endothelial cells. Evidence for receptor recycling Biochem J., 257, 875-884.
29. Pertoft, H and Smedsröd, B. (1987) Separation and characterization of liver cells In Pretlow, T.G. and Pretlow, T.P. (eds.), Cell Separation: Methods and Selected Applications. Academic Press, New York, pp. 1-24.
30. Raja, R.H., McGary, C.T. and Weigel, P.H. (1988) Affinity and distribution of surface and intracellular hyaluronic receptors in isolated rat liver endothelial cells. J. Biol Chem., 263, 16661-16668.
31. Rodén, L. Campbell, P., Fraser, J.R.E., Laurent, T.C. Pertoft, H. and Thompson, J.N. (1989) Enzymic pathways of hyaluronan catabolism. In Evered, D. and Whelan, J. (eds.), The Biology of Hyaluronan. Ciba Foundation Symposium 143. Wiley, Chichester, pp. 60-86.
32. Rooney, P., Kumar, S., Ponting, J. and Wang, M. (1995) The role of hyaluronan in tumor neovascularization. Int. J. Cancer, 60, 632-636.
33. Seed, M.P., Freemantle, C., Brown, J., Alam, C.A.S. and Willoughby, D.A. (1995a) The inhibition of neutrophil-endothelial cell adhesion by hyaluronan, a ligand for ICAM-1. In Willoughby, D.A. (ed.), Third International Workshop on Hyaluronan in Drug Delivery. Round Table Series 40. Royal Society of Medicine Press, London, pp. 82-87.
34. Seed, M.P., Freemantle, C., Gustafson, S., Brown, J., Alam, C. Peretti, M., Newbold, P., Dwivedi, A., Carrier, M. and Willoughby, D.A. (1995b) The inhibition of neutrophil-endothelial cell adhesion by hyaluronan, a ligand for ICAM-1. Inflammation Res., 44(S3), S245.
35. Smedsröd, B. (1991) Cellular events in the uptake and degradation of hyaluronan Adv. Drug Deliv. Rev., 7, 265-278
36. Smedsröd, B., Pertoft, H., Eriksson, S., Fraser, J.R.E. and Laurent, T.C. (1984) Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells Biochem. J., 223, 617-626.
37. Smedsröd, B., Pertoft, H., Gustafson, S. and Laurent, T.C. (1990) Scavenger functions of the liver endothelial cell Biochem. J., 266, 313-327
38. Tengblad, A., Laurent, U.B.G., Lilja, K., Cahill, R.N., Engstrom-Laurent, A., Fraser, J.R.E., Hansson, H.E. and Laurent, T.C. (1986) Concentration and relative molecular mass of hyaluronate in lymph and blood. Biochem. J., 236, 521-525
39. Tzaicos, C., Fraser, J.R.E., Tsotsis, E. and Kimpton, W.G. (1989) Inhibition of hyaluronan uptake in lymphatic tissue by chondroitin sulphate proteoglycan Biochem. J., 264, 823-828
40. Zugmaier, G., Lippman, M.E. and Wellstein, A. (1992) Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals. J. Natl. Cancer Inst., 84, 1716-1724.